These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17416480)

  • 1. Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement.
    Gottenberg JE; Mahr A; Pagnoux C; Cohen P; Mouthon L; Guillevin L;
    Presse Med; 2007 May; 36(5 Pt 1):771-8. PubMed ID: 17416480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival and relapses assessment in patients with Wegener's granulomatosis and predominant renal involvement].
    Zycińska K; Wardyn KA
    Pol Arch Med Wewn; 2007 Apr; 117(4):16-24. PubMed ID: 17722471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of survival and organ damage in Wegener's granulomatosis.
    Koldingsnes W; Nossent H
    Rheumatology (Oxford); 2002 May; 41(5):572-81. PubMed ID: 12011383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
    Haubitz M; Koch KM; Brunkhorst R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
    Villa-Forte A; Clark TM; Gomes M; Carey J; Mascha E; Karafa MT; Roberson G; Langford CA; Hoffman GS
    Medicine (Baltimore); 2007 Sep; 86(5):269-277. PubMed ID: 17873756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up.
    Mahr A; Girard T; Agher R; Guillevin L
    Rheumatology (Oxford); 2001 May; 40(5):492-8. PubMed ID: 11371656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum tolerable dose of cyclophosphamide and azathioprine in Pakistani patients with primary renal disease.
    Ali SS; Rabbani MA; Moinuddin SS; Virani S; Farooque F; Salam A; Ahmad A
    J Pak Med Assoc; 2004 Jan; 54(1):39-42. PubMed ID: 15058645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal histopathology and clinical course in patients with Wegener's granulomatosis--single centre experience from the Republic of Macedonia.
    Grcevska L; Ristovska V; Nikolov V; Milovanceva-Popovska M; Petrusevska G; Kostadinova-Kunovska S; Polenakovic M
    Prilozi; 2011; 32(1):69-86. PubMed ID: 21822179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
    Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
    Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.
    Eriksson P; Jacobsson L; Lindell A; Nilsson JA; Skogh T
    J Intern Med; 2009 Apr; 265(4):496-506. PubMed ID: 19141094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of patients with Wegener's granulomatosis treated with plasma exchange.
    Aasarød K; Iversen BM; Hammerstrøm J; Bostad L; Jørstad S
    Blood Purif; 2002; 20(2):167-73. PubMed ID: 11818680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with Wegener's granulomatosis diagnosed in Finland in 1981-2000.
    Takala JH; Kautiainen H; Leirisalo-Repo M
    Scand J Rheumatol; 2010; 39(1):71-6. PubMed ID: 20132074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.
    Ozbalkan Z; Kiraz S; Ozturk MA; Ertenli AI; Apras S; Calguneri M
    Clin Rheumatol; 2006 May; 25(3):358-63. PubMed ID: 16362442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and treatment of elderly patients with ANCA-associated vasculitis.
    Weiner M; Goh SM; Mohammad AJ; Hruskova Z; Tanna A; Bruchfeld A; Selga D; Chocova Z; Westman K; Eriksson P; Pusey CD; Tesar V; Salama AD; Segelmark M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1128-35. PubMed ID: 26100457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis--clinical course and long-term outcome.
    Frascà GM; Zoumparidis NG; Borgnino LC; Neri L; Neri L; Vangelista A; Bonomini V
    Int J Artif Organs; 1993 Jan; 16(1):11-9. PubMed ID: 8458666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.
    Zäuner I; Bach D; Braun N; Krämer BK; Fünfstück R; Helmchen U; Schollmeyer P; Böhler J
    Am J Kidney Dis; 2002 Jan; 39(1):28-35. PubMed ID: 11774098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related variations in presentation and outcome in Wegener's granulomatosis.
    Vassallo M; Shepherd RJ; Iqbal P; Feehally I
    J R Coll Physicians Lond; 1997; 31(4):396-400. PubMed ID: 9263968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.